Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely. J. Hepatol. 2013, 58, 676–683. [CrossRef] [PubMed] 21. Lai, C.L.; Wong, D.; Ip, P.; Kopaniszen, M.; Seto, W.K.; ...
Since this study was conducted with Brazilian participants, who are highly heterogeneous and admixed, it is important to emphasize the influence of demographic covariates, such as age and body surface area, but also the proportion of African ancestry, which combined with the pharmacogenetic marker ...
Keywords: hepatitis B virus; hepadnaviridae; hepatitis B surface antigen; envelope proteins; core protein; virions; subviral particles; secretion; virus evolution 1. Introduction Hepatitis B virus (HBV) is an enveloped DNA virus with a small circular genome of 3.2 kb [1,2]. The 1.2-kb ...
Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: Finite treatment duration unlikely. J. Hepatol. 2013, 58, 676–683. [CrossRef] [PubMed] 21. Lai, C.L.; Wong, D.; Ip, P.; Kopaniszen, M.; Seto, W.K.; Fung, J.; Huang, F.Y....